← Back to Treatments
🏅 FDA Orphan Designation

Avaclyr

acyclovir

Manufacturer: Fera Pharmaceuticals

Indicated for:
OBSOLETE: Herpes simplex virus keratitis

FDA-Approved Indications (1)

indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus

Population: all ages

Indications & Usage

1 INDICATIONS AND USAGE AVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus. AVACLYR (acyclovir ophthalmic ointment) 3%, a herpes simplex virus nucleoside analog DNA polymerase inhibitor, is indicated in the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus.

💙 Support Programs

View all →
Acyclovir
GlaxoSmithKline
Copay card ↗Apply ↗
Avaclyr
Fera Pharmaceuticals

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.